Back to results
US 2017/0285041 A1Published application
Method for determining risk of pre-eclampsia
AssigneeWallac Oy
InventorsTarja Ahola, Heikki Kouru, Mikko Sairanen
Life of this patent
Estimating the term…
Abstract
The present description relates to a method for determining the risk of a pregnant woman with chronic hypertension developing early or late onset pre-eclampsia. The present description provides methods useful for determining risk that a pregnant individual with chronic hypertension will develop an early pre-eclampsia or late pre-eclampsia. Useful combination of biochemical markers including PlGF and sP-Selectin and related clinical population studies are described herein.
Claims4
Method for determining the risk of pre-eclampsia in a pregnant individual with chronic hypertension, comprising:
- determining the levels of biochemical markers including Placental growth factor (PlGF) and sP-selectin in at least one blood sample from the individual;
- and determining the risk of pre-eclampsia using the determined levels of biochemical markers, wherein the levels of said biochemical markers are compared to control values of the same biochemical markers, and wherein a difference in the levels of said biochemical markers compared to control values of the same biochemical markers is indicative of early onset or late onset pre-eclampsia.
Dependencies are inferred from the claim text.